• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促黄体生成素/人绒毛膜促性腺激素的作用与卵巢癌的发展——关于生物学及临床/流行病学方面的简短综述

LH/hCG action and development of ovarian cancer--a short review on biological and clinical/epidemiological aspects.

作者信息

Mandai Masaki, Konishi Ikuo, Kuroda Hideki, Fujii Shingo

机构信息

Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.

出版信息

Mol Cell Endocrinol. 2007 Apr 15;269(1-2):61-4. doi: 10.1016/j.mce.2006.11.014. Epub 2007 Feb 6.

DOI:10.1016/j.mce.2006.11.014
PMID:17353087
Abstract

A link between infertility therapy, especially ovulation induction therapy using gonadotropins, and the development of ovarian cancer has long been an issue of debate since an epidemiological report supporting the possibility appeared in 1992. A number of clinical/epidemiological and biological studies, including a few that we conducted, have revealed various facts regarding this issue. The aim of this short review was to summarize the last 10 years findings and to address the implications of the debates on this issue.

摘要

自1992年一份支持这种可能性的流行病学报告出现以来,不孕治疗,尤其是使用促性腺激素的促排卵治疗与卵巢癌的发生之间的联系一直是一个有争议的问题。包括我们进行的一些研究在内的许多临床/流行病学和生物学研究,都揭示了关于这个问题的各种事实。这篇简短综述的目的是总结过去10年的研究结果,并探讨关于这个问题的争论的意义。

相似文献

1
LH/hCG action and development of ovarian cancer--a short review on biological and clinical/epidemiological aspects.促黄体生成素/人绒毛膜促性腺激素的作用与卵巢癌的发展——关于生物学及临床/流行病学方面的简短综述
Mol Cell Endocrinol. 2007 Apr 15;269(1-2):61-4. doi: 10.1016/j.mce.2006.11.014. Epub 2007 Feb 6.
2
Review: gonadotropins and development of ovarian cancer.综述:促性腺激素与卵巢癌的发展
Oncology. 1999 Oct;57 Suppl 2:45-8. doi: 10.1159/000055274.
3
[Assessment of expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR) and hCG protein in ovarian cancer tissues].[卵巢癌组织中促黄体生成素(LH)/人绒毛膜促性腺激素(hCG)受体(LH/hCGR)及hCG蛋白表达的评估]
Ginekol Pol. 2007 Dec;78(12):939-43.
4
Novel biological and possible applicable roles of LH/hCG receptor.促黄体生成素/人绒毛膜促性腺激素受体的新型生物学及可能的应用作用
Mol Cell Endocrinol. 2007 Apr 15;269(1-2):51-60. doi: 10.1016/j.mce.2006.08.016. Epub 2007 Feb 7.
5
Ovulation induction treatment and risk of borderline ovarian tumors.促排卵治疗与卵巢交界性肿瘤的风险
Gynecol Endocrinol. 2007 Jul;23(7):373-6. doi: 10.1080/09513590701350341.
6
Gonadotropins and the uterus: is there a gonad-independent pathway?促性腺激素与子宫:是否存在不依赖性腺的途径?
J Soc Gynecol Investig. 2001 Nov-Dec;8(6):319-26.
7
Fertility drugs and ovarian cancer risk: a critical review of the literature.生育药物与卵巢癌风险:文献综述的批判性评估。
Ann N Y Acad Sci. 2010 Sep;1205:214-9. doi: 10.1111/j.1749-6632.2010.05668.x.
8
Human adrenal cortex hyperfunction due to LH/hCG.由促黄体生成素/人绒毛膜促性腺激素引起的人类肾上腺皮质功能亢进。
Mol Cell Endocrinol. 2007 Apr 15;269(1-2):46-50. doi: 10.1016/j.mce.2006.06.014. Epub 2007 Feb 11.
9
Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility.人绒毛膜促性腺激素的新概念:生殖系统相互作用及在不孕症管理中的潜力
Fertil Steril. 2005 Aug;84(2):275-84. doi: 10.1016/j.fertnstert.2005.02.033.
10
[Gonadotropins and ovarian cancer].[促性腺激素与卵巢癌]
Ginekol Pol. 2005 Feb;76(2):153-62.

引用本文的文献

1
Tumor Markers and Their Diagnostic Significance in Ovarian Cancer.肿瘤标志物及其在卵巢癌中的诊断意义
Life (Basel). 2023 Aug 5;13(8):1689. doi: 10.3390/life13081689.
2
Epidemiological trends and risk factors of gynecological cancers: an update.妇科癌症的流行病学趋势和风险因素:最新研究进展。
Med Oncol. 2023 Feb 9;40(3):93. doi: 10.1007/s12032-023-01957-3.
3
Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses.转基因雌性生殖系统过度表达 LH 受体的小鼠会自发形成子宫内膜肿瘤团块。
Sci Rep. 2021 Apr 23;11(1):8847. doi: 10.1038/s41598-021-87492-5.
4
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.接受卵巢刺激药物治疗不孕症的女性患卵巢癌的风险。
Cochrane Database Syst Rev. 2019 Jun 18;6(6):CD008215. doi: 10.1002/14651858.CD008215.pub3.
5
β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway.β-hCG 通过 ERK/MMP2 信号通路促进上皮性卵巢癌转移。
Cell Cycle. 2019 Jan;18(1):46-59. doi: 10.1080/15384101.2018.1558869. Epub 2018 Dec 24.
6
Use of fertility medications and cancer risk: a review and update.生育药物的使用与癌症风险:综述与更新
Curr Opin Obstet Gynecol. 2017 Aug;29(4):195-201. doi: 10.1097/GCO.0000000000000370.
7
Recent concepts of ovarian carcinogenesis: type I and type II.卵巢癌发生的最新概念:I型和II型。
Biomed Res Int. 2014;2014:934261. doi: 10.1155/2014/934261. Epub 2014 Apr 23.
8
CGB activates ERK and AKT kinases in cancer cells via LHCGR-independent mechanism.CGB通过不依赖LHCGR的机制激活癌细胞中的ERK和AKT激酶。
Tumour Biol. 2014 Jun;35(6):5467-79. doi: 10.1007/s13277-014-1715-5. Epub 2014 Feb 20.
9
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.接受卵巢刺激药物治疗不孕症的女性患卵巢癌的风险。
Cochrane Database Syst Rev. 2013 Aug 13;2013(8):CD008215. doi: 10.1002/14651858.CD008215.pub2.
10
Activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10.蛋白激酶C(PKC)信号通路的激活会刺激卵巢癌细胞的增殖、迁移以及基质金属蛋白酶7(MMP7)和基质金属蛋白酶10(MMP10)的表达。
Biol Reprod. 2013 Sep 27;89(3):73. doi: 10.1095/biolreprod.112.102327. Print 2013 Sep.